Global Health Limited
Simbols: MEDANTA.NS
NSE
1407
INRTirgus cena šodien
83.0259
P/E koeficients
0.0000
PEG koeficients
377.79B
MRK Cap
- 0.00%
DIV ienesīgums
Global Health Limited (MEDANTA-NS) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 13107.8 | 5118.1 | 2893 | |||||
balance-sheet.row.short-term-investments | 0 | 5435.4 | 3923.8 | 2198.3 | |||||
balance-sheet.row.net-receivables | 0 | 1942 | 2423.8 | 1655 | |||||
balance-sheet.row.inventory | 0 | 603.7 | 533.9 | 397.6 | |||||
balance-sheet.row.other-current-assets | 0 | 141.3 | 41.5 | 1730.7 | |||||
balance-sheet.row.total-current-assets | 0 | 15794.9 | 8117.2 | 5021.3 | |||||
balance-sheet.row.property-plant-equipment-net | 0 | 23719 | 22088.5 | 20722.4 | |||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.intangible-assets | 0 | 51.7 | 62.7 | 72.5 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 51.7 | 62.7 | 72.5 | |||||
balance-sheet.row.long-term-investments | 0 | -5005.5 | -3818.9 | -2009.8 | |||||
balance-sheet.row.tax-assets | 0 | 257.1 | 277.9 | 257.4 | |||||
balance-sheet.row.other-non-current-assets | 0 | 6342.6 | 4727.8 | 2877.2 | |||||
balance-sheet.row.total-non-current-assets | 0 | 25364.8 | 23337.9 | 21919.7 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 0 | 41159.6 | 31455.2 | 26941 | |||||
balance-sheet.row.account-payables | 0 | 1946.9 | 1343.3 | 1315.5 | |||||
balance-sheet.row.short-term-debt | 0 | 1393.6 | 1055.9 | 1029.5 | |||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.long-term-debt-total | 0 | 9825.9 | 10033.3 | 8284.2 | |||||
Deferred Revenue Non Current | 0 | 669.7 | 218.7 | 363.4 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||
balance-sheet.row.other-current-liab | 0 | 983.5 | 23.7 | 14.1 | |||||
balance-sheet.row.total-non-current-liabilities | 0 | 11152 | 11100.3 | 9071 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 0 | 2797.3 | 2710.6 | 2867.8 | |||||
balance-sheet.row.total-liab | 0 | 16877.6 | 15295.1 | 13117.6 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 325 | |||||
balance-sheet.row.common-stock | 0 | 536.4 | 506.4 | 820.9 | |||||
balance-sheet.row.retained-earnings | 0 | 12837.9 | 9529.6 | 7689.8 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 237.3 | 274.5 | 442.5 | |||||
balance-sheet.row.other-total-stockholders-equity | 0 | 10670.5 | 5849.6 | 4545.2 | |||||
balance-sheet.row.total-stockholders-equity | 0 | 24282.1 | 16160.1 | 13823.4 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 41159.6 | 31455.2 | 26941 | |||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-equity | 0 | 24282.1 | 16160.1 | 13823.4 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||
Total Investments | 0 | 429.9 | 104.9 | 188.6 | |||||
balance-sheet.row.total-debt | 0 | 11219.5 | 11089.3 | 9313.8 | |||||
balance-sheet.row.net-debt | 0 | 3547.1 | 9894.9 | 8619.1 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 4492.9 | 2805.6 | 324.6 | |||||
cash-flows.row.depreciation-and-amortization | 0 | 1499.1 | 1297.1 | 1232.1 | |||||
cash-flows.row.deferred-income-tax | 0 | -7.5 | -874.5 | 131.7 | |||||
cash-flows.row.stock-based-compensation | 0 | 7.5 | 17.4 | 37.9 | |||||
cash-flows.row.change-in-working-capital | 0 | 1028.2 | -667.7 | 365.9 | |||||
cash-flows.row.account-receivables | 0 | -214.6 | -495.6 | 102.9 | |||||
cash-flows.row.inventory | 0 | -69.8 | -136.3 | -12.4 | |||||
cash-flows.row.account-payables | 0 | 603.6 | 27.8 | 8.1 | |||||
cash-flows.row.other-working-capital | 0 | 709 | -63.5 | 267.4 | |||||
cash-flows.row.other-non-cash-items | 0 | -582.6 | 534.7 | 325.4 | |||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -2359.9 | -2744.8 | -1457.4 | |||||
cash-flows.row.acquisitions-net | 0 | 8 | 13.8 | 38 | |||||
cash-flows.row.purchases-of-investments | 0 | -1416.1 | -1725.4 | -1172.8 | |||||
cash-flows.row.sales-maturities-of-investments | 0 | -8 | 83.7 | 50.4 | |||||
cash-flows.row.other-investing-activites | 0 | 352.5 | 163.8 | 150.3 | |||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -3423.4 | -4208.9 | -2391.5 | |||||
cash-flows.row.debt-repayment | 0 | -666.5 | -198.9 | -30.2 | |||||
cash-flows.row.common-stock-issued | 0 | 4785.5 | 379.5 | 2.4 | |||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||
cash-flows.row.other-financing-activites | 0 | -662.6 | 1415.2 | -779.4 | |||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 3456.4 | 1595.9 | -807.2 | |||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||
cash-flows.row.net-change-in-cash | 0 | 6478.1 | 499.7 | -781 | |||||
cash-flows.row.cash-at-end-of-period | 0 | 7672.4 | 1194.3 | 694.7 | |||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1194.3 | 694.7 | 1475.7 | |||||
cash-flows.row.operating-cash-flow | 0 | 6445.2 | 3112.6 | 2417.7 | |||||
cash-flows.row.capital-expenditure | 0 | -2359.9 | -2744.8 | -1457.4 | |||||
cash-flows.row.free-cash-flow | 0 | 4085.3 | 367.9 | 960.3 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 26942.5 | 21559.7 | 14306.1 | |||||
income-statement-row.row.cost-of-revenue | 0 | 6252.8 | 5429.3 | 3485.6 | |||||
income-statement-row.row.gross-profit | 0 | 20689.6 | 16130.4 | 10820.6 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 0 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | 649.1 | 122.4 | 80 | |||||
income-statement-row.row.operating-expenses | 0 | 15990.5 | 12730.5 | 9893.6 | |||||
income-statement-row.row.cost-and-expenses | 0 | 22243.3 | 18159.8 | 13379.2 | |||||
income-statement-row.row.interest-income | 0 | 346.2 | 167.2 | 177.6 | |||||
income-statement-row.row.interest-expense | 0 | 779.2 | 789.5 | 671 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 0 | -855.4 | -594.3 | -602.3 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | 649.1 | 122.4 | 80 | |||||
income-statement-row.row.total-operating-expenses | 0 | -855.4 | -594.3 | -602.3 | |||||
income-statement-row.row.interest-expense | 0 | 779.2 | 789.5 | 671 | |||||
income-statement-row.row.depreciation-and-amortization | 0 | 1499.1 | 1297.1 | 1232.1 | |||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||
income-statement-row.row.operating-income | 0 | 5348.3 | 3399.9 | 927 | |||||
income-statement-row.row.income-before-tax | 0 | 4492.9 | 2805.6 | 324.6 | |||||
income-statement-row.row.income-tax-expense | 0 | 1232.1 | 843.6 | 36.6 | |||||
income-statement-row.row.net-income | 0 | 3260.8 | 1962 | 288.1 |
Biežāk uzdotie jautājumi
Kas ir Global Health Limited (MEDANTA.NS) kopējie aktīvi?
Global Health Limited (MEDANTA.NS) kopējie aktīvi ir 41159640000.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir N/A.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.768.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir 12.311.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir 0.143.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir 0.226.
Kāda ir Global Health Limited (MEDANTA.NS) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir 3260793000.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 11219519000.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 15990499000.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 0.000.